Trial Profile
Double-blind Randomized study comparing Baloxavir Marboxil to Peramivir in pediatric patients with Influenza
Status:
Discontinued
Phase of Trial:
Phase IV
Latest Information Update: 11 Dec 2018
Price :
$35
*
At a glance
- Drugs Baloxavir-marboxil (Primary) ; Peramivir
- Indications Influenza virus infections
- Focus Therapeutic Use
- 03 Dec 2018 Status changed from not yet recruiting to discontinued.
- 19 Nov 2018 New trial record